321 related articles for article (PubMed ID: 21381407)
1. [Comparative clinical efficacy of a probiotic vs. an antibiotic in the treatment of patients with intestinal bacterial overgrowth and chronic abdominal functional distension: a pilot study].
Soifer LO; Peralta D; Dima G; Besasso H
Acta Gastroenterol Latinoam; 2010 Dec; 40(4):323-7. PubMed ID: 21381407
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO)--a pilot study.
Khalighi AR; Khalighi MR; Behdani R; Jamali J; Khosravi A; Kouhestani Sh; Radmanesh H; Esmaeelzadeh S; Khalighi N
Indian J Med Res; 2014 Nov; 140(5):604-8. PubMed ID: 25579140
[TBL] [Abstract][Full Text] [Related]
3. Glucose breath test and Crohn's disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response.
Greco A; Caviglia GP; Brignolo P; Ribaldone DG; Reggiani S; Sguazzini C; Smedile A; Pellicano R; Resegotti A; Astegiano M; Bresso F
Scand J Gastroenterol; 2015; 50(11):1376-81. PubMed ID: 25990116
[TBL] [Abstract][Full Text] [Related]
4. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.
Pimentel M; Chow EJ; Lin HC
Am J Gastroenterol; 2000 Dec; 95(12):3503-6. PubMed ID: 11151884
[TBL] [Abstract][Full Text] [Related]
5. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study.
Myllyluoma E; Veijola L; Ahlroos T; Tynkkynen S; Kankuri E; Vapaatalo H; Rautelin H; Korpela R
Aliment Pharmacol Ther; 2005 May; 21(10):1263-72. PubMed ID: 15882248
[TBL] [Abstract][Full Text] [Related]
6. Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease.
Kwak DS; Jun DW; Seo JG; Chung WS; Park SE; Lee KN; Khalid-Saeed W; Lee HL; Lee OY; Yoon BC; Choi HS
Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1353-9. PubMed ID: 25244414
[TBL] [Abstract][Full Text] [Related]
7. Small intestinal bacterial overgrowth: diagnosis and treatment.
Gasbarrini A; Lauritano EC; Gabrielli M; Scarpellini E; Lupascu A; Ojetti V; Gasbarrini G
Dig Dis; 2007; 25(3):237-40. PubMed ID: 17827947
[TBL] [Abstract][Full Text] [Related]
8. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
Cremonini F; Di Caro S; Covino M; Armuzzi A; Gabrielli M; Santarelli L; Nista EC; Cammarota G; Gasbarrini G; Gasbarrini A
Am J Gastroenterol; 2002 Nov; 97(11):2744-9. PubMed ID: 12425542
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
10. Effect of Bifidobacterium infantis 35624 (Align) on the Lactulose Breath Test for Small Intestinal Bacterial Overgrowth.
Kumar K; Saadi M; Ramsey FV; Schey R; Parkman HP
Dig Dis Sci; 2018 Apr; 63(4):989-995. PubMed ID: 29397491
[TBL] [Abstract][Full Text] [Related]
11. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome.
Nobaek S; Johansson ML; Molin G; Ahrné S; Jeppsson B
Am J Gastroenterol; 2000 May; 95(5):1231-8. PubMed ID: 10811333
[TBL] [Abstract][Full Text] [Related]
12. Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.
Weinstock LB; Geng B; Brandes SB
Can J Urol; 2011 Aug; 18(4):5826-30. PubMed ID: 21854715
[TBL] [Abstract][Full Text] [Related]
13. The role of a probiotics mixture in the treatment of childhood constipation: a pilot study.
Bekkali NL; Bongers ME; Van den Berg MM; Liem O; Benninga MA
Nutr J; 2007 Aug; 6():17. PubMed ID: 17683583
[TBL] [Abstract][Full Text] [Related]
14. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of antibiotherapy for treating flatus incontinence associated with small intestinal bacterial overgrowth: A pilot randomized trial.
Melchior C; Gourcerol G; Bridoux V; Ducrotté P; Quinton JF; Leroi AM
PLoS One; 2017; 12(8):e0180835. PubMed ID: 28763464
[TBL] [Abstract][Full Text] [Related]
16. Small intestine bacterial overgrowth in patients with irritable bowel syndrome.
Carrara M; Desideri S; Azzurro M; Bulighin GM; Di Piramo D; Lomonaco L; Adamo S
Eur Rev Med Pharmacol Sci; 2008; 12(3):197-202. PubMed ID: 18700692
[TBL] [Abstract][Full Text] [Related]
17. Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children.
Goldman CG; Barrado DA; Balcarce N; Rua EC; Oshiro M; Calcagno ML; Janjetic M; Fuda J; Weill R; Salgueiro MJ; Valencia ME; Zubillaga MB; Boccio JR
Nutrition; 2006 Oct; 22(10):984-8. PubMed ID: 16978844
[TBL] [Abstract][Full Text] [Related]
18. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
[TBL] [Abstract][Full Text] [Related]
19. [Small intestinal bacterial overgrowth in patients with functional gastrointestinal diseases].
Madrid AM; Defilippi C C; Defilippi G C; Slimming A J; Quera P R
Rev Med Chil; 2007 Oct; 135(10):1245-52. PubMed ID: 18180830
[TBL] [Abstract][Full Text] [Related]
20. [Small intestine bacterial overgrowth in patients with chronic diarrhea and normal control subjects].
Torres Lam R; León Barúa R; Berendson Seminario R; Curioso Vílchez W; Roe Battistini E; Biber Poillevard M
Rev Gastroenterol Peru; 2003; 23(2):111-4. PubMed ID: 12853987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
